prikaz prve stranice dokumenta HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
Access restricted to all Croatian higher education institution's students and staff
Scientific paper - Original scientific paper
HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
Molecular Biology Reports, 3 (2011); 2253-2258. https://doi.org/10.1007/s11033-011-0974-0
Buretić-Tomljanović, Alena; Vraneković, Jadranka; Rubeša, Gordana; Tomljanović, Draško; Šendula - Jengić, Vesna; Kapović, Miljenko; Ristić, Smiljana

Cite this document

Buretić Tomljanović, A., Vraneković, J., Rubeša, G., Tomljanović, D., Šendula Jengić, V., Kapović, M. & Ristić, S. (2011). HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder. Molecular Biology Reports, 3., 2253-2258. doi: 10.1007/s11033-011-0974-0

Buretić Tomljanović, Alena, et al. "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder." Molecular Biology Reports, vol. 3, 2011, pp. 2253-2258. https://doi.org/10.1007/s11033-011-0974-0

Buretić Tomljanović, Alena, Jadranka Vraneković, Gordana Rubeša, Draško Tomljanović, Vesna Šendula Jengić, Miljenko Kapović and Smiljana Ristić. "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder." Molecular Biology Reports 3 (2011): 2253-2258. https://doi.org/10.1007/s11033-011-0974-0

Buretić Tomljanović, A., et al. (2011) 'HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder', Molecular Biology Reports, 3, pp. 2253-2258. doi: 10.1007/s11033-011-0974-0

Buretić Tomljanović A, Vraneković J, Rubeša G, Tomljanović D, Šendula Jengić V, Kapović M, and sur.. HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder. Molecular Biology Reports [Internet]. 2011 June 04 [cited 2024 November 12];3:2253-2258. doi: 10.1007/s11033-011-0974-0

A. Buretić Tomljanović, et al., "HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder", Molecular Biology Reports, vol. 3, pp. 2253-2258, June 2011. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:058200. [Accessed: 12 November 2024]

Please login to the repository to save this object to your list.
Metadata
Title (english)HFE mutations and transferrin C1/C2 polymorphism among Croatian patients with schizophrenia and schizoaffective disorder
AuthorAlena Buretić-Tomljanović
AuthorJadranka Vraneković
AuthorGordana Rubeša
AuthorDraško Tomljanović
AuthorVesna Šendula - Jengić
AuthorMiljenko Kapović
AuthorSmiljana Ristić
MBZ: 142283
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Biology and Medical Genetics)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Basic Medical Sciences
Human Genetics, Genomics and Proteomics
Abstract (english)
The aim of this study was to investigate the possible influence of hemochromatosis gene mutations (HFE-C282Y and H63D) and transferrin gene C2 variant (TF-C2) on susceptibility to schizophrenia and schizoaffective disorder and/or age at first hospital admission. Genotyping was performed in 176 Croatian patients and 171 non-psychiatric Croatian controls using PCR-RFLP analyses. Regarding the H63D mutation, allele and genotype frequencies reached boundary statistical significance. Other allele and genotype distributions were not significantly different between two groups. We also analyzed age at first hospital admission as a continuous variable using the non-parametric Mann–Whitney U-test and Kruskal–Wallis test, and multiple regression analysis. The results of these tests were negative. We concluded that investigated HFE mutations and TF-C2 variant are not high-risk genetic variants for schizophrenia/schizoaffective disorder in our population. Also our data do not support their impact on age at onset of the first psychotic symptoms.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleMolecular Biology Reports
Numberingvol. 3, pp. 2253-2258
e-ISSN1573-4978
DOIhttps://doi.org/10.1007/s11033-011-0974-0
URN:NBNurn:nbn:hr:184:058200
Publication2011-06-04
ProjectNumber: 062-0982522-0369
Title (croatian): Genetika metabolizma fosfolipida u shizofreniji
Title (english): Genetics of phospholipid metabolism in schizophrenia
Leader: Alena Buretić-Tomljanović
Jurisdiction: Croatia
Funding stream: ZP
Document URLhttps://link.springer.com/article/10.1007/s11033-011-0974-0/fulltext.html#Sec1
Type of resourceText
Access conditionsRestricted access
Terms of useLicence In copyright icon
Created on2017-05-16 10:11:12